<p>Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.</p>

Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Sign up to save your podcasts

Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

More shows like Neurology Minute

JAMA Editors' Summary

Neurology® Podcast

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

JAMA Neurology Author Interviews

JAMA Medical News

Neurology Today in 5

Annals On Call Podcast

Navigating Neuropsychology

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio